ArticleBiomedical optics express2026
Retinal fluid segmentation in real-world OCT imaging of neovascular AMD using hybrid deep learning and graph-based optimization.
Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Accurate segmentation and quantification of retinal fluid in optical coherence tomography (OCT) images are important for assessing disease activity and treatment response in neovascular age-related macular degeneration (nvAMD). Yet, manual delineation of intraretinal fluid (IRF), subretinal fluid (SRF), and pigment epithelial detachment (PED) is labor-intensive and subject to inter-grader variability. We developed a hybrid framework for robust retinal fluid segmentation in clinical-grade longitudinal OCT, combining anatomically constrained retinal-region extraction using Deep LOGISMOS with nnU-Net-based 2-D and 3-D fluid segmentation. To improve adaptation to heterogeneous clinical data while reducing annotation burden, an iterative expert-guided labeling strategy was used, starting with 70 RETOUCH OCT scans and 100 scans from subjects with macular neovascularization at the University of Iowa and expanding to a final aggregated training set of 291 scans. The method was validated on a held-out test set of 50 OCT volumes from 50 nvAMD subjects, with a subset of 20 volumes independently annotated by a second expert for inter-observer analysis. It was further applied to a longitudinal dataset of 14,500 Heidelberg Spectralis macular OCT scans from 221 independent subjects. The ensemble model achieved Dice similarity coefficients (%) of 89.5±11.7 for IRF, 88.0±10.7 for SRF, and 82.0±13.0 for PED against the primary expert annotations, with performance approaching expert-level agreement. In longitudinal inference, our developed framework supports robust large-scale quantification of fluid burden and spatial extent across heterogeneous scan protocols and extended follow-up. The artificial intelligence-based approach has the potential to enable scalable and clinically meaningful longitudinal analysis of retinal fluid in nvAMD.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.